| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 29,713 | 34,977 | ||
| Accounts receivable, net of allowances of 239 and 275 | 11,274 | 11,236 | ||
| Inventory | 11,558 | 11,371 | ||
| Prepaid expenses and other current assets | 3,503 | 3,161 | ||
| Total current assets | 56,048 | 60,745 | ||
| Property and equipment, net | 2,213 | 2,167 | ||
| Other long-term assets | - | 1,131 | ||
| Intangible assets, net | 1,454 | 1,549 | ||
| Right-of-use assets | 1,560 | 1,616 | ||
| Deferred tax asset, net | 62 | 64 | ||
| Restricted cash | 250 | 265 | ||
| Total assets | 61,587 | 67,537 | ||
| Current portion of long-term debt | - | 3,333 | ||
| Accounts payable | 2,373 | 1,741 | ||
| Accrued expenses and other current liabilities | 14,604 | 13,987 | ||
| Total current liabilities | 16,977 | 19,061 | ||
| Longterm debt | 41,494 | 38,051 | ||
| Other longterm liabilities | 1,559 | 1,241 | ||
| Total liabilities | 60,030 | 58,353 | ||
| Common stock 0.001 par value 200,000,000 shares authorized 40,341,535 and 39,395,712 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 40 | 40 | ||
| Additional paid-in capital | 389,946 | 388,968 | ||
| Accumulated other comprehensive income | 91 | 93 | ||
| Accumulated deficit | -388,520 | -379,917 | ||
| Total stockholders' equity | 1,557 | 9,184 | ||
| Total liabilities and stockholders' equity | 61,587 | 67,537 | ||
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)